Development and Application of Virtual Reality (VR) and Human Computer Interaction System in the ICU Patients
NCT ID: NCT05522400
Last Updated: 2022-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
244 participants
INTERVENTIONAL
2021-05-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
Virtual Reality (VR) and human computer interaction system
The experimental group used VR technology and human-computer interaction system for exercise, while the control group used traditional exercise program
control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality (VR) and human computer interaction system
The experimental group used VR technology and human-computer interaction system for exercise, while the control group used traditional exercise program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Voluntary participation
Exclusion Criteria
* High dose of vasoactive drugs to maintain vital signs;
* Acute stroke;
* Upper limb fractures or amputations;
* Patients with spinal fracture or pathological fracture;
* Patients who have been hospitalized for 30 days or more before admission to ICU;
* Plan to move out of ICU within 24 hours; In palliative care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wenyan PAN
Role: PRINCIPAL_INVESTIGATOR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
180 Fenglin Road
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wenyan PAN
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020ZSLC68
Identifier Type: -
Identifier Source: org_study_id